MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 269 filers reported holding MYRIAD GENETICS INC in Q3 2013. The put-call ratio across all filers is 2.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $215,000 | -12.6% | 7,900 | -8.1% | 0.04% | -8.9% |
Q3 2019 | $246,000 | +0.8% | 8,600 | -2.3% | 0.04% | -11.8% |
Q2 2019 | $244,000 | -67.8% | 8,800 | -61.4% | 0.05% | -69.1% |
Q1 2019 | $757,000 | +73.6% | 22,800 | +51.9% | 0.16% | +57.1% |
Q4 2018 | $436,000 | -36.8% | 15,010 | 0.0% | 0.10% | -26.1% |
Q3 2018 | $690,000 | +84.0% | 15,010 | +50.1% | 0.14% | +610.0% |
Q3 2015 | $375,000 | +10.3% | 10,000 | 0.0% | 0.02% | +17.6% |
Q2 2015 | $340,000 | -52.0% | 10,000 | -50.0% | 0.02% | -52.8% |
Q1 2015 | $708,000 | +4.0% | 20,000 | 0.0% | 0.04% | +2.9% |
Q4 2014 | $681,000 | -11.7% | 20,000 | 0.0% | 0.04% | -14.6% |
Q3 2014 | $771,000 | -1.0% | 20,000 | -0.0% | 0.04% | +105.0% |
Q2 2014 | $779,000 | +13.9% | 20,010 | 0.0% | 0.02% | -47.4% |
Q1 2014 | $684,000 | +30.5% | 20,010 | -20.0% | 0.04% | +26.7% |
Q4 2013 | $524,000 | -10.9% | 25,000 | 0.0% | 0.03% | -16.7% |
Q3 2013 | $588,000 | -12.5% | 25,000 | 0.0% | 0.04% | -16.3% |
Q2 2013 | $672,000 | – | 25,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 3,309,206 | $109,866,000 | 6.94% |
SG Capital Management LLC | 604,159 | $20,058,000 | 3.66% |
KESTREL INVESTMENT MANAGEMENT CORP | 232,975 | $7,735,000 | 3.57% |
Broadfin Capital, LLC | 500,000 | $16,600,000 | 3.43% |
Tieton Capital Management, LLC | 98,199 | $3,260,000 | 2.90% |
SG Capital Management LLC | 350,000 | $11,620,000 | 2.12% |
DISCIPLINED GROWTH INVESTORS INC /MN | 2,852,064 | $94,689,000 | 1.66% |
Broadfin Capital, LLC | 240,000 | $7,968,000 | 1.64% |
Millrace Asset Group, Inc. | 58,302 | $1,936,000 | 1.63% |
PURA VIDA INVESTMENTS, LLC | 300,000 | $9,960,000 | 1.42% |